Canadian vitamin maker Jamieson up for sale by CCMP: sources

By Lauren Hirsch, Denny Thomas and John Tilak NEW YORK/HONG KONG/TORONTO (Reuters) - U.S. private equity firm CCMP Capital Advisors is trying to sell Jamieson Laboratories about two years after buying the Canadian vitamin maker, according to three sources familiar with the situation. CCMP, which has hired investment banks Houlihan Lokey and Nomura to facilitate the sale, has received some approaches from potential buyers, said the sources, who spoke on condition of anonymity as the matter was not public. One source said Jamieson could go for a multiple of 12 to 14 times EBITDA, which would be roughly $600 million to $700 million.